Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical Practice | Zendy

Jyoji Nakagawara | Zendy; Kazuo Minematsu | Zendy; Yasushi Okada | Zendy; Norio Tanahashi | Zendy; Shinji Nagahiro | Zendy; Etsuro Mori | Zendy; Yukito Shinohara | Zendy; Takenori Yamaguchi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical Practice

Author(s) -

Jyoji Nakagawara,

Kazuo Minematsu,

Yasushi Okada,

Norio Tanahashi,

Shinji Nagahiro,

Etsuro Mori,

Yukito Shinohara,

Takenori Yamaguchi

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.110.589606

Subject(s) - medicine , thrombolysis , modified rankin scale , confidence interval , stroke (engine) , observational study , subgroup analysis , christian ministry , surgery , ischemic stroke , myocardial infarction , ischemia , mechanical engineering , philosophy , theology , engineering

In Japan, alteplase at 0.6 mg/kg was approved in October 2005 for use within 3 hours of stroke onset by the Ministry of Health, Labor and Welfare (MHLW). The aim of the Japan post-Marketing Alteplase Registration Study (J-MARS), which was requested by MHLW at the time of approval, was to assess the safety and efficacy of 0.6 mg/kg alteplase in routine clinical practice for the Japanese.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research